Workflow
ImmunityBio(IBRX) - 2019 Q3 - Quarterly Report
ImmunityBioImmunityBio(US:IBRX)2019-11-06 05:06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Registrant's telephone number, including area code: (858) 633-0300 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From _____ to _____ Commission file number: 001-37507 NANTKWEST, INC. (Exact Name of Registr ...